Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 99 results found. Search for [ Lupin share price ]

Results 1 to 21 of 99
BusinessToday.In
November 11, 2019
Amara Raja's stock opened with a gain of 3.36% today and later jumped 11.58% to touch the intraday high of Rs 729.75 on the BSE


BusinessToday.In
November 11, 2019
The 'Advertising & Media' sector firm also reported a healthy  evenue from operations that surged 40.4% to Rs 84.7 crore as against Rs 60.3 crore in the same quarter last year


BusinessToday.In
November 8, 2019
The share purchase by Jhunjhunwala comes at a time when YES Bank finds itself on a sticky wicket in terms of its financial position


BusinessToday.In
New Delhi, November 7, 2019
HPCL Q2 results: Total income in July-September dipped 9.40 per cent to Rs 66,850.89 crore against Rs 73,789.50 crore in Q2FY19


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


BusinessToday.In
New Delhi, November 6, 2019
Lupin Q2 results: Consolidated revenue from operations of the pharma major increased 10.3 per cent year-on-year (YoY) to Rs 4,359.7 crore in Q2FY20 as against Rs 3,951 crore in Q2FY19


BusinessToday.In
New Delhi, October 7, 2019
Weighed down by USFDA observations, share price of Aurobindo Pharma declined as much as 20.65 per cent to hit a 52-week low of Rs 450 on the BSE, after opening tad lower at Rs 560 against previous close level of Rs 567.15 on the BSE


E Kumar Sharma
September 5, 2019
Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India


PTI
August 7, 2019
Drug firm Lupin on Wednesday reported a 49.46 per cent rise in consolidated net profit to Rs 303.05 crore for the quarter ended June 30, 2019 on account of robust sales in India and overseas.


BusinessToday.In
June 7, 2019
Share Market Update: Domestic equity benchmark indices closed marginally higher, after a volatile trading session today.


BusinessToday.In
May 27, 2019
Lupin share price fell declined 5.43 per cent to Rs 721.50 on the BSE. On the NSE, shares dropped 5.67 per cent to Rs 720. Lupin share price opened at a loss of 2.48% at 744 in trade today compared to the previous close of 762.95 on BSE.


PTI
May 17, 2019
Revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same quarter last fiscal, the city-based drug-maker said in a press release.


E Kumar Sharma
New Delhi, May 16, 2019
Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.


BusinessToday.In
May 15, 2019
Share Market Updates: Shedding gains of the trading session Wednesday, benchmark indices closed in the red. Other major indices gave up all intraday gains to turn negative in trade as well.


Mudit Kapoor
May 14, 2019
Severe penalties could be levied on the Indian pharma companies varying from $13 million to $873 million; Glenmark could face the highest penalty, while Aurobindo the least.


Aprajita Sharma
May 14, 2019
The ongoing trade war between the US and China had triggered the recent correction in the market


BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


BusinessToday.In
May 14, 2019
Markets Live: While Sensex is trading 263 points higher at 37,354, Nifty is up 83 points to 11,231.70. Sun Pharma, Vedanta and ICICI Bank were the top gainers on Sensex. Tata Steel, Bajaj Auto and Asian Paints were the top losers on Sensex.


BusinessToday.In
May 9, 2019
 Indian equity market extended losses for the seventh consecutive session on Thursday led by decline in Power, Pharma, Energy indices. Escalated trade tensions between China and the US also prompted investors to remain cautious throughout the trading session.


BusinessToday.In
April 24, 2019
Except auto, all other sectoral indices ended in green backed up by gains in bank, IT, energy, telecom and finance.


PAGES 1 OF 5  12345